
27.10.2020
К. Б. Мирзаев; Ю. Ю. Киселёв; Д. А. Сычёв
distress-syndrome in COVID-19, including combined use with tocilizumab, has been identified. Systemic

27.10.2020
Ю. Ю. Киселёв; К. Б. Мирзаев; Д. А. Сычёв
of acute respiratory distress-syndrome in patients with COVID-19, and such treatment is not supported

27.10.2020
Ю. Ю. Киселёв; В. М. Цветов; К. Б. Мирзаев; Д. А. Сычёв
of the treatment alternatives for severe COVID-19, yet this treatment is not preferable. It requires careful